Motilal Oswal Nifty MidSmall Healthcare Index Fund - Growth - Direct Plan

Other Plans and Options
  • 0.6 %Nav, as on 17-04-2025

  • Previous Nav

  • Net Change on 17-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index,subject to tracking error.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Nifty MidSmall Healthcare - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Motilal Oswal Nifty 500 Index Fund - Direct Plan Sep 06, 2019 6.77 13.35 23.81 0.20 2,102.31
Motilal Oswal Nifty Midcap 150 Index Fund - Direct Plan Sep 06, 2019 6.80 19.45 31.57 0.30 1,986.88
Axis Nifty 100 Index Fund - Direct Plan - Growth Option Oct 18, 2019 7.67 11.96 21.73 0.21 1,715.36
Motilal Oswal Nifty Smallcap 250 Index Fund- Direct Plan Sep 06, 2019 1.93 16.30 33.57 0.36 791.62
Motilal Oswal Nifty Bank Index Fund - Direct Plan Sep 06, 2019 15.05 13.79 21.45 0.33 593.54

Fund Holdings as on 31-March-2025

  • Max Healthcare Institute Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Aurobindo Pharma Limited

  • Mankind Pharma Limited

  • Alkem Laboratories Limited

  • Laurus Labs Limited

  • Glenmark Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Abbott India Limited

  • Krishna Institute Of Medical Sciences Limited

  • Biocon Limited

  • Suven Pharmaceuticals Limited

  • Piramal Pharma Limited

  • Syngene International Limited

  • Gland Pharma Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Narayana Hrudayalaya Limited

  • Ajanta Pharma Limited

  • Aster DM Healthcare Limited

  • Neuland Laboratories Limited

  • Global Health Limited

  • Dr. Lal Path Labs Limited

  • Poly Medicure Limited

  • Natco Pharma Limited

  • Granules India Limited

  • Rainbow Childrens Medicare Limited

  • Pfizer Limited

  • Alembic Pharmaceuticals Limited

  • Collateralized Borrowing & Lending Obligation

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal Nifty MidSmall Healthcare Index Fund

Scheme Analysis

Motilal Oswal Nifty MidSmall Healthcare Index Fund is a Index Funds - Other fund and belongs to Motilal Oswal Mutual Fund. It was launched on 19-Nov-2024 and currently has an AUM of ₹23.50 crore. Motilal Oswal Nifty MidSmall Healthcare Index Fund is benchmarked against Nifty MidSmall Healthcare - TRI as primary index.

The NAV of Motilal Oswal Nifty MidSmall Healthcare Index Fund ended up ₹0.06(0.6%)yesterday to ₹9.8629.

Among its top 3 holdings the fund has exposure to Max Healthcare Institute Limited, and

The Motilal Oswal Nifty MidSmall Healthcare Index Fund is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022 40548002
amc@motilaloswal.com
022-22816161